These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6264162)

  • 21. Intracellular state of Epstein-Barr virus DNA in producer cell lines.
    Gussander E; Adams A
    J Gen Virol; 1979 Nov; 45(2):331-40. PubMed ID: 232128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.
    Yajima Y; Tanaka A; Nonoyama M
    Virology; 1976 May; 71(1):352-4. PubMed ID: 179207
    [No Abstract]   [Full Text] [Related]  

  • 23. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.
    Sato H; Takimoto T; Tanaka S; Tanaka J; Raab-Traub N
    J Virol; 1990 Nov; 64(11):5295-300. PubMed ID: 2170673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
    Lin JC; Smith MC; Pagano JS
    Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus genomes with properties of circular DNA molecules in carrier cells.
    Adams A; Lindahl T
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1477-81. PubMed ID: 165511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase I and II activities are required for Epstein-Barr virus replication.
    Kawanishi M
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2263-8. PubMed ID: 8409949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells.
    Kaschka-Dierich C; Falk L; Bjursell G; Adams A; Lindahl T
    Int J Cancer; 1977 Aug; 20(2):173-80. PubMed ID: 197024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular forms of Epstein-Barr virus DNA in Raji cells.
    Adams A; Lindahl T
    IARC Sci Publ (1971); 1975; (11 Pt 1):125-32. PubMed ID: 190113
    [No Abstract]   [Full Text] [Related]  

  • 32. Replication of African swine fever virus DNA in infected cells.
    Rojo G; García-Beato R; Viñuela E; Salas ML; Salas J
    Virology; 1999 May; 257(2):524-36. PubMed ID: 10329562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on replication of Epstein-Barr virus in human lymphoblastoid cell lines.
    Lin JC; Smith MC; Choi EI; De Clercq E; Verbruggen A; Pagano JS
    Antiviral Res; 1985; Suppl 1():121-6. PubMed ID: 3002251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of concatemeric DNA as an intermediate in the replication of bacteriophage T1 DNA molecules.
    Ritchie DA; Joicey DH
    J Gen Virol; 1978 Dec; 41(3):609-22. PubMed ID: 370347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal lengths for DNAs encapsidated by Epstein-Barr virus.
    Bloss TA; Sugden B
    J Virol; 1994 Dec; 68(12):8217-22. PubMed ID: 7966614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication of Epstein-Barr virus DNA in epithelial cells in vivo.
    Lemon SM; Hutt LM; Shaw JE; Li JL; Pagano JS
    IARC Sci Publ (1971); 1978; (24 Pt 2):739-44. PubMed ID: 221397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection.
    Moar MH; Klein G
    Intervirology; 1980; 13(3):178-85. PubMed ID: 6246034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the replicative structures of the DNA of a herpesvirus (pseudorabies).
    Ben-Porat T; Jean JH; Blankenship ML; Tokazewski S
    IARC Sci Publ (1971); 1978; (24 Pt 1):63-73. PubMed ID: 221363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
    Church TM; Verma D; Thompson J; Swaminathan S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.
    Flamand L; Stefanescu I; Ablashi DV; Menezes J
    J Virol; 1993 Nov; 67(11):6768-77. PubMed ID: 8411380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.